The TAAR5 agonist α-NETA causes dyskinesia in mice.
Dyskinesia
TAAR5
Tardive dyskinesia
Trace amine-associated receptors
Trace amines
α-NETA
Journal
Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130
Informations de publication
Date de publication:
21 06 2019
21 06 2019
Historique:
received:
06
03
2019
revised:
02
04
2019
accepted:
09
04
2019
pubmed:
16
4
2019
medline:
6
2
2020
entrez:
16
4
2019
Statut:
ppublish
Résumé
It is known that trace amine-associated receptor 5 (TAAR5) is expressed in various regions of the central nervous system. However, very limited information is available on the behavioral effects of TAAR5 activation and the TAAR5 functional role, in general. We studied the effect of TAAR5 agonist (2-(alpha-naphthoyl) ethyltrimethylammonium iodide) systemic administration on animal behavior. The study was performed on male C57BL/6 mice. It was observed that α-NETA in 10 mg/kg dose caused specific impairment of motor behavior, similar to the manifestations of tardive dyskinesia in humans. It can be assumed that trace amines and TAAR5 may be involved in the human tardive dyskinesia pathogenesis.
Identifiants
pubmed: 30986441
pii: S0304-3940(19)30262-9
doi: 10.1016/j.neulet.2019.04.028
pii:
doi:
Substances chimiques
Naphthalenes
0
Quaternary Ammonium Compounds
0
Receptors, G-Protein-Coupled
0
trace amine-associated receptor 5, mouse
0
2-naphthoylethyltrimethylammonium
31059-54-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
208-211Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.